摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氰基氨基-4-羟基-6-甲基嘧啶 | 7152-19-4

中文名称
2-氰基氨基-4-羟基-6-甲基嘧啶
中文别名
——
英文名称
N-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)cyanamide
英文别名
(4-methyl-6-oxo-1,6-dihydro-pyrimidin-2-yl)-carbamonitrile;(1,4-dihydro-6-methyl-4-oxo-2-pyrimidinyl)-cyanamide;2-Cyanoamino-4-Hydroxy-6-Methylpyrimidine;(4-methyl-6-oxo-1H-pyrimidin-2-yl)cyanamide
2-氰基氨基-4-羟基-6-甲基嘧啶化学式
CAS
7152-19-4
化学式
C6H6N4O
mdl
MFCD00023201
分子量
150.14
InChiKey
WGBRHUINONWPFT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.5
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.166
  • 拓扑面积:
    77.3
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933599090

SDS

SDS:7b7440d40a121e9f83ca0992f291d2bb
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Crowther et al., Journal of the Chemical Society, 1948, p. 586,590
    摘要:
    DOI:
  • 作为产物:
    描述:
    乙酰乙酸乙酯二聚氰胺 在 sodium hydroxide 作用下, 以 为溶剂, 反应 12.0h, 生成 2-氰基氨基-4-羟基-6-甲基嘧啶
    参考文献:
    名称:
    通过1-(6-氧代-1,6-二氢嘧啶-2-基)胍与原乙酸三乙酯的反应 区域选择性合成嘧啶并[1,2- a ] [1,3,5]三嗪-6-酮:意外的重新安排†
    摘要:
    在(6-氧代-1,6-二氢嘧啶-2-基)胍3(其中NR 1 R 2 = NH 2,NH烷基,NH芳烷基,NHCH 2 Ph(R))与原乙酸三乙酯得到4-取代的-2-甲基-6 H-嘧啶基[1,2- a ] [1,3,5]三嗪-6-ones 6及其开环产物。但是,对于带有叔氨基或苯胺基取代基的(6-氧代-1,6-二氢嘧啶-2-基)胍3,未观察到这样的重排(即NR 1 R 2 = N(CH 3)2,吲哚啉,吗啉代,NHAr)。如所预期的,获得2-取代的-4-甲基-6 H-嘧啶基[1,2- a ] [1,3,5]三嗪-6-酮4作为最终产物。进行了实验结构确定和理论研究,以了解所观察到的热重排。此外,尝试使用以下方法获得相似的嘧啶并[1,2- a ] [1,3,5] triazin-6-onesN,N-二甲基乙酰胺二甲基乙缩醛(DMA-DMA)作为一个碳插入合成子,由于与第二个DMA-DMA分子进一
    DOI:
    10.1039/c2ob25195g
点击查看最新优质反应信息

文献信息

  • 1-(2-Oxyaminosulphonylphenylsulphonyl)-3-heteroaryl-ureas
    申请人:Bayer Aktiengesellschaft
    公开号:US04666505A1
    公开(公告)日:1987-05-19
    The invention relates to new 1-(2-oxyaminosulphonylphenylsulphonyl)-3-heteroaryl-ureas of the general formula (I) ##STR1## in which R.sup.1 represents an optionally substituted radical from the series comprising alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkylalkyl, aralkyl and aryl, R.sup.2 represents hydrogen or an optionally substituted radical from the series comprising alkyl, alkenyl, alkinyl and aralkyl and R.sup.3 represents an optionally substituted and/or optionally fused six-membered aromatic heterocyclic radical containing at least one nitrogen atom, the following compounds being excluded: 1-(2-methoxyaminosulphonylphenylsulphonyl)-, 1-(2-ethoxyaminosulphonylphenylsulphonyl)-, 1-(2-propoxy-aminosulphonylphenylsulphonyl)-, 1-(2-isopropoxyaminosulphonylphenylsulphonyl)- and 1-(2-butoxyaminosulphonylphenylsulphonyl)-3-(4,6-dimethyl-pyrimidin-2-yl)- urea, -3-(4,6-diethyl-pyrimidin-2-yl)-urea, -3-(4,6-dipropylpyrimidin-2-yl)-urea, -3-(4,6-diisopropyl-pyrimidin-2-yl)-urea and -3-(4,6-dibutyl-pyrimidin-2-yl)-urea, processes for their preparation and their use as herbicides.
    本发明涉及一类新的1-(2-氧氨基磺酰基苯磺酰基)-3-杂芳基脲,其具有通式(I)的结构,其中R1代表一个可选地取代的基团,该基团选自包括烷基、烯基、炔基、环烷基、环烷基烷基、芳烷基和芳基的系列;R2代表氢或一个可选地取代的基团,该基团选自包括烷基、烯基、炔基和芳烷基的系列;R3代表一个可选地取代和/或可选地融合的六元芳香杂环基团,含有至少一个氮原子,排除以下化合物:1-(2-甲氧氨基磺酰基苯磺酰基)-,1-(2-乙氧氨基磺酰基苯磺酰基)-,1-(2-丙氧氨基磺酰基苯磺酰基)-,1-(2-异丙氧氨基磺酰基苯磺酰基)-和1-(2-丁氧氨基磺酰基苯磺酰基)-3-(4,6-二甲基嘧啶-2-基)-脲,-3-(4,6-二乙基嘧啶-2-基)-脲,-3-(4,6-二丙基嘧啶-2-基)-脲,-3-(4,6-二异丙基嘧啶-2-基)-脲和-3-(4,6-二丁基嘧啶-2-基)-脲,以及这些化合物的制备方法和作为除草剂的使用方法。
  • 1-(2-oxyaminosulphonylphenylsulphonyl)-3-triazinyl-ureas
    申请人:Bayer Aktiengesellschaft
    公开号:US04820337A1
    公开(公告)日:1989-04-11
    Herbicidally active 1-(2-oxyaminosulphenylphenylsulphonyl)-3-triazinyl-ureas of the formula ##STR1## in which X is nitrogen, Y is nitrogn, Z is C-R.sup.6 and R.sup.1, R.sup.2, R.sup.4 and R.sup.6 are various organic radicals.
    具有除草活性的1-(2-氧氨基磺酰基苯磺酰基)-3-三嗪基脲,其分子式为##STR1##,其中X是氮,Y是氮,Z是C-R.sup.6,而R.sup.1、R.sup.2、R.sup.4和R.sup.6是各种有机基团。
  • An efficient synthesis of 2,4,7-trisubstituted pyrimido[1,2-a][1,3,5]triazin-6-ones
    作者:Nikhil Sachdeva、Anton V. Dolzhenko、Seow Joo Lim、Wee Ling Ong、Wai Keung Chui
    DOI:10.1039/c5nj00405e
    日期:——
    5]triazin-6-one scaffold was successfully achieved by the introduction of substituents into positions 2 and 7 via two complementary approaches for the synthesis of key intermediates viz. pyrimidinylguanidines. Variations in position 4 of the pyrimido[1,2-a][1,3,5]triazine ring were made available by the regioselective introduction of various substituents via the triazine ring closure with corresponding aldehydes
    开发了一种制备在环的2、4和7位官能化的新型嘧啶并[1,2- a ] [1,3,5]三嗪-6-衍生物的方法。嘧啶并[1,2- a ] [1,3,5]三嗪-6-一个骨架的衍生化多样性是通过两种互补方法将取代基引入位置2和7来合成关键中间体而成功实现的即 嘧啶基胍。嘧啶并[1,2- a ] [1,3,5]三嗪环第4位的变化可通过以下方法实现:三嗪与相应的醛一起闭环。该方法的范围通过制备66个嘧啶并[1,2- a ] [1,3,5] triazin-6- one的文库进行了说明,事实证明该文库是新的选择性抗癌药的来源。还研究了所制备化合物的互变异构偏好性和抗癌特性。
  • Patterns of Informal and Formal Caregiving Among Elders With Private Long-Term Care Insurance
    作者:Marc A. Cohen、Jessica Miller、Maurice Weinrobe
    DOI:10.1093/geront/41.2.180
    日期:2001.4.1
    Purpose: The purpose of this report is to provide basic descriptive information on community-dwelling, disabled, private long-term care (LTC) insurance policyholders who have accessed policy benefits. We focus on how benefits are used, whether claimants feel they are getting appropriate value from their policies, and what the patterns are of formal and informal service use. Design and Methods: Data were obtained from a nationally representative sample of 693 LTC insurance claimants who were receiving benefits while living in the community and 424 of their informal caregivers. Eight of the largest LTC insurance companies representing about 80% of the market participated in the study. Results: LTC insurance benefits are well targeted; they serve those truly dependent on ongoing care. The vast majority of claimants are satisfied with their policies, understand their coverage, and find it easy to file claims. Because of their LTC benefits, substantial numbers of disabled elderly individuals report that they are able to remain at home instead of being forced to seek institutional care. The availability of LTC benefits reduces stress among informal caregivers. For most claimants, formal care did not replace informal caregiving. Implications: As the LTC insurance market continues to grow and mature, there will be changes in the profile of claimants, the service delivery system, and the design of policies. Expansions in the private market will be associated with a greater number of disabled elderly remaining in their homes with a maintenance of and enhanced resiliency of informal support networks.
    目的:本报告的目的是提供有关在社区中居住的残疾人士、私人长期护理(LTC)保险保单持有者的基本描述性信息,这些保单持有者已经使用了保单福利。我们关注福利的使用情况、索赔人是否感到从保单中获得了适当的价值,以及正式和非正式服务使用的模式。 设计与方法:数据来自全国代表性样本,共有693名在社区内接受福利的LTC保险索赔人和424名非正式护理人员参与了研究。参与研究的八家最大的LTC保险公司占据了大约80%的市场。 结果:LTC保险福利针对性良好;这些福利服务于那些真正依赖于持续护理的人。绝大多数索赔人对他们的保单感到满意,理解他们的保障内容,并且觉得申请索赔比较容易。由于拥有LTC福利,大量残疾老年人报告称他们能够留在家中,而不是被迫寻求机构护理。LTC福利的可用性减少了非正式护理人员的压力。对于大多数索赔人而言,正式护理并没有取代非正式照顾。 影响:随着LTC保险市场的不断增长和成熟,索赔人的特征、服务提供系统和保单设计将会发生变化。私人市场的扩展将与更多残疾老年人留在家中、非正式支持网络的维护和增强的韧性相关联。
  • 1-(2-oxyaminosulphonylphenylsulphonyl)-3-heteroaryl-iso-(thio)-ureas
    申请人:Bayer Aktiengesellschaft
    公开号:US04659364A1
    公开(公告)日:1987-04-21
    Herbicidally active novel 1-(2-oxyaminosulphonylphenylsulphonyl)-3-heteroaryl-iso (thio)-ureas of the formula ##STR1## in which R is optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl-alkyl, cycloalkyl, aralkyl, aryl or heteryl, R.sup.1 is optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkyl-alkyl, aralkyl or aryl, R.sup.2 is hydrogen, or optionally substituted alkyl, alkenyl, alkinyl or aralkyl, R.sup.3 is an optionally substituted and/or optionally fused 6-membered aromatic heterocycle which contains at least one nitrogen atom, and Q is oxygen or sulphur, or strong acid-adducts thereof.
    具有草甘膦活性的新型1-(2-氧胺磺酰基苯基磺酰基)-3-杂环基-异(硫)脲的化合物,其化学式为##STR1## 其中,R是可选取的取代基的烷基、烯基、炔基、环烷基-烷基、环烷基、芳基烷基、芳基或杂芳基;R.sup.1是可选取的取代基的烷基、烯基、炔基、环烷基、环烷基-烷基、芳基烷基或芳基;R.sup.2是氢,或可选取的取代基的烷基、烯基、炔基或芳基烷基;R.sup.3是可选取的取代基和/或可选取的融合6元芳香杂环,其中含有至少一个氮原子;Q是氧或硫,或其强酸加合物。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台